Trial Profile
Adapalene vs. Placebo as Prophylaxis for anti-EGFRs-induced Acne-like rash, a Randomized left-right Comparative Evaluation (APPEARANCE)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2019
Price :
$35
*
At a glance
- Drugs Adapalene (Primary) ; Minocycline
- Indications Acne
- Focus Therapeutic Use
- Acronyms APPEARANCE
- 05 Jun 2018 Primary endpoint (The difference in total facial lesion count of acne-like rash at 4 weeks) has not been met, as per the results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 05 Jun 2018 Results (n=26) evaluating the prophylactic efficacy presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 06 Mar 2018 Status changed from active, no longer recruiting to completed.